Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Neon Therapeutics, Inc. (NTGN)
|
Add to portfolio |
|
|
|
| Price: |
$3.07
| | Metrics |
| OS: |
29.0
|
M
| |
-522
|
% ROE
|
| Market cap: |
$88.9
|
M
| |
-1202
|
% ROIC
|
|
Net cash:
|
$15
|
M
| |
$0.52
|
per share
|
|
EV:
|
$73.9
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($74.6)
|
M
| |
|
|
|
EBIT
|
($76.2)
|
M
| |
|
|
| EPS |
($2.69)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 |
| Research and development | 59.7 | 60.4 | 37.2 | 19.7 |
| General and administrative | 21.4 | 18.3 | 10.9 | 7.7 |
| EBIT | -81.1 | -78.7 | -48.1 | -27.4 |
| Pre-tax income | -79.8 | -76.9 | -47.5 | -27.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -79.8 | -83.3 | -57.9 | -30.4 |
| |
| Diluted EPS | ($2.86) | ($5.54) | ($34.32) | ($30.72) |
| Shares outstanding (diluted) | 27.9 | 15.0 | 1.7 | 1.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|